Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01649661 · ClinicalTrials.gov registry record
MRI Parenchymal Enhancement: A New Marker of Breast Cancer Risk
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 437
- Enrollment target
NCT01649661: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT01649661 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 437 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01649661 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 437 participants
- Enrollment target
Study Summary
The purpose of this study is to learn about how a woman's health history influences what a normal breast looks like on an MRI. The investigators also want to learn about how the amount of different natural hormones a woman has affects how the breast looks on an MRI. The investigator's hope is that this will help to find women at a high-risk of breast cancer.
Primary Outcome
A comparison of the distribution of breast cancer risk factors in women with low and high levels of BPE. The relationship between risk factors and categories of BPE (minimal/mild/moderate/marked) will be determined using ordinal logistic regression.
Interventions
- BEHAVIORAL questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 437 participants |
| Start Date | 2012-07 |
| Est. Completion | 2023-01-25 |
What the finished NCT01649661 record still lists
NCT01649661 is an observational study that tracks outcomes without assigning an intervention. The registered 437 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which questionnaire is the first listed.
NCT01649661 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01649661 about?
NCT01649661 is a clinical study titled "MRI Parenchymal Enhancement: A New Marker of Breast Cancer Risk". The purpose of this study is to learn about how a woman's health history influences what a normal breast looks like on an MRI. The investigators also want to learn about how the amount of different natural hormones a woman has affects how the breast looks on an MRI. The investigator's hope is that t...
What is the current status of trial NCT01649661?
This trial is currently completed. The enrollment target is 437 participants. The study started on 2012-07. Estimated completion is 2023-01-25.
What interventions are being tested in trial NCT01649661?
The interventions under investigation include: questionnaire (BEHAVIORAL).
Who is sponsoring clinical trial NCT01649661?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05711446 · 438 participants · NA
Double Voiding and Post-transplant UTI
- NCT02622542 · 436 participants · NA
ACute Uncomplicated Type b Aortic Dissection: Endovascular Repair vs. Best Medical Therapy
- NCT05918211 · 436 participants · Phase 3
Fontan Udenafil Exercise Longitudinal Assessment Trial - 2
- NCT06966479 · 436 participants · Phase 2
A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia